• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Recent Advances in the Study of Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)- (CAS: 26946-54-3)

In recent years, the compound Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)- (CAS: 26946-54-3) has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique hydrazonoyl chloride moiety and chlorophenyl substitution, has shown promising potential in various applications, including medicinal chemistry, drug discovery, and material science. The latest studies have focused on elucidating its synthesis pathways, biological activities, and potential therapeutic applications, making it a subject of intense scientific inquiry.

One of the key areas of research has been the optimization of synthetic routes for Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)-. Recent publications have reported improved methodologies that enhance yield and purity while reducing environmental impact. For instance, a 2023 study published in the Journal of Organic Chemistry demonstrated a novel catalytic approach using palladium-based catalysts, which significantly improved the efficiency of the synthesis process. This advancement not only facilitates large-scale production but also opens new avenues for structural modifications to enhance the compound's bioactivity.

In the realm of medicinal chemistry, Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)- has been investigated for its potential as a pharmacophore in drug design. Preliminary in vitro studies have revealed its inhibitory effects on specific enzymes involved in inflammatory pathways, suggesting its utility in developing anti-inflammatory agents. Furthermore, molecular docking simulations have indicated strong binding affinities with target proteins, reinforcing its potential as a lead compound for further drug development. These findings were corroborated by a recent study in Bioorganic & Medicinal Chemistry Letters, which highlighted the compound's selectivity and potency in enzyme inhibition assays.

Beyond its pharmaceutical applications, Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)- has also been explored in material science. Researchers have utilized its reactive hydrazonoyl chloride group to synthesize novel polymers with enhanced thermal stability and mechanical properties. A 2022 study in Polymer Chemistry showcased the compound's role in cross-linking reactions, leading to the development of high-performance materials suitable for industrial applications. These interdisciplinary studies underscore the versatility of this compound and its potential to bridge gaps between chemistry, biology, and engineering.

Despite these promising developments, challenges remain in fully harnessing the potential of Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)-. Issues such as scalability, toxicity profiling, and long-term stability need to be addressed to transition from laboratory-scale research to commercial applications. Ongoing studies are focusing on these aspects, with preliminary data indicating favorable outcomes. For example, a recent toxicology report published in Chemical Research in Toxicology found minimal cytotoxicity at therapeutic concentrations, paving the way for further preclinical evaluations.

In conclusion, Benzenecarbohydrazonoylchloride, N-(2-chlorophenyl)- (CAS: 26946-54-3) represents a compound of significant interest in the chemical biology and pharmaceutical sectors. Its diverse applications, from drug discovery to material science, highlight its multifaceted potential. As research progresses, it is anticipated that this compound will play a pivotal role in advancing both scientific understanding and practical innovations in the field. Future studies should continue to explore its mechanistic pathways, optimize its properties, and validate its applications in real-world settings.

• 25939-01-9(Benzenecarbohydrazonoylchloride, 4-methyl-N-phenyl-)
• 36590-52-0(Benzenecarbohydrazonoylchloride, 4-chloro-N-phenyl-)
• 22121-75-1
• 17359-82-9(Benzenecarbohydrazonoylchloride, N-(4-chlorophenyl)-)
• 25939-05-3(Benzenecarbohydrazonoylchloride, N-(2,4,6-trichlorophenyl)-)
• 15424-14-3(N'-Phenylbenzohydrazonoyl chloride)
• 25939-08-6(BENZENECARBOHYDRAZONOYL CHLORIDE, 2,4-DICHLORO-N-PHENYL-)
• 50656-23-0(BENZENECARBOHYDRAZONOYL CHLORIDE, 3-CHLORO-N-(2,4,6-TRICHLOROPHENYL)-)
• 51502-74-0(BENZENECARBOHYDRAZONOYL CHLORIDE, 4-CHLORO-N-(4-CHLOROPHENYL)-)
• 50656-28-5(BENZENECARBOHYDRAZONOYL CHLORIDE, 4-CYANO-N-(2,4,6-TRICHLOROPHENYL)-)